Background: The extraordinarily large number of possible encodings in natural genes is to some extent restricted by two encoding biases referred to as codon bias and codon pair bias. An unexplored aspect of the genetic architecture of HIV-1 is how codon choice influences population diversity and evolvability. Here we compared the development of HIV-1 resistance to protease inhibitors (PIs) of WT virus and a synthetic virus (MAX) carrying a codon-pair re-engineered protease sequence with 38 (13%) synonymous mutations.
Methods: The re-coded protease gene segment (MAX) was synthesized de novo and recombined to an HXB2 HIV-1 infectious clone. By serial culture passages WT and MAX viruses were subjected to the selective pressure of PIs [atazanavir (ATV) and darunavir (DRV)].
Results: WT and MAX virus replicated indistinguishably in MT-4 cells or PBMCs. An initial sequence analysis of individual clones demonstrated that after one passage in MT-4 cells WT protease quasispecies diversity (p-distance) was significantly higher than that of the virus carrying the MAX protease either at the nucleotide level (0.0016 ± 0.0001 vs 0.0014 ± 0.0000, p=0.0033, unpaired t test) or at the amino acid level (0.0034 ± 0.0001 vs 0.0023 ± 0.0001, p< 0.00001). This result indicated that WT and MAX proteases may occupy different sequence spaces. To explore the evolvability of the codon pair re-coded protease, WT and MAX viruses were growth under the selective pressure of ATV and DRV. After the same number of serial passages in MT-4 cells in the presence of PIs, WT and MAX viruses developed phenotypic resistance to PIs (IC50 14.63±5.39 nM and 21.26±8.67 nM, for ATV; and IC50 5.69±1.01µM and 9.35±1.89 for DRV, respectively). Sequence clonal analysis showed the presence, in both viruses, of resistance mutations to ATV and DRV. However, a different resistance variant repertoire appeared in the MAX virus protease. Specifically, the G16E substitution was only observed in the WT protease. In addition, L10F, L33F, K45I, G48L and L89I substitutions were only detected in the re-coded MAX protease population.
Conclusions: The differences in the mutation pattern that emerged after PIs treatment suggested again that WT and MAX virus proteases occupy different sequence spaces although both virus proteases were able to develop PIs resistance. Further studies will required to elucidate whether HIV-1 sequences have evolved to optimize not only the protein coding sequence but also the DNA/RNA sequences.